Reduced frequency of HIV superinfection in a high-risk cohort in Zambia

scientific article published on 15 June 2019

Reduced frequency of HIV superinfection in a high-risk cohort in Zambia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VIROL.2019.06.009
P932PMC publication ID7179746
P698PubMed publication ID31254743

P2093author name stringJill Gilmour
Susan Allen
Eric Hunter
Ilene Brill
William Kilembe
Debby Basu
Evonne Woodson
Hope Olszewski
P2860cites workShort Communication: A Recombinant Variant with Increased Envelope Entry Efficiency Emerged During Early Infection of an HIV-1 Subtype C Dual Infected Rapid ProgressorQ36656789
Multiplexed highly-accurate DNA sequencing of closely-related HIV-1 variants using continuous long reads from single molecule, real-time sequencingQ36676496
Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfectionQ36763288
Dynamics of HIV type 1 recombination following superinfectionQ36842102
Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responsesQ36994644
Transmission of HIV-1 in the face of neutralizing antibodiesQ37017806
Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfectionQ37336404
HIV-1 Superinfection and its Implications for Vaccine DesignQ37807440
Sustained effect of couples' HIV counselling and testing on risk reduction among Zambian HIV serodiscordant couples.Q39023570
Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody ResponseQ40159859
Risk of heterosexual HIV transmission attributable to sexually transmitted infections and non-specific genital inflammation in Zambian discordant couples, 1994-2012.Q40246165
HIV-1 superinfection can occur in the presence of broadly neutralizing antibodiesQ47254280
Recombination following superinfection by HIV-1.Q48967809
Superinfection Drives HIV Neutralizing Antibody Responses from Several B Cell Lineages that Contribute to a Polyclonal Repertoire.Q52718554
HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization BreadthQ57071746
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody TitersQ60908099
A patient with HIV-1 superinfectionQ74735775
HIV-1 superinfection in women broadens and strengthens the neutralizing antibody responseQ21090490
Identifying HIV-1 dual infectionsQ22241756
Dual HIV-1 infection associated with rapid disease progressionQ28247153
HIV superinfectionQ28259889
HIV drug resistance acquired through superinfectionQ28264308
Immune-correlates analysis of an HIV-1 vaccine efficacy trialQ29617377
New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical dataQ31160798
Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infectionQ33504604
Comprehensive Characterization of Humoral Correlates of Human Immunodeficiency Virus 1 Superinfection Acquisition in High-risk Kenyan WomenQ33603702
Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune CorrelatesQ33742529
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitroQ33853775
Low antibody-dependent cellular cytotoxicity responses in Zambians prior to HIV-1 intrasubtype C superinfectionQ34016675
Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virusQ34120140
Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in ZambiaQ34327190
Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug usersQ34343410
Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequencesQ34577539
Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1Q34648079
HIV-1 superinfectionQ35581046
The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single InfectionQ35686970
HIV-1 superinfection is associated with an accelerated viral load increase but has a limited impact on disease progressionQ35854639
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infectionQ35857268
Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate virusesQ35950936
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodiesQ36262823
Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.Q36306344
HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfectionQ36334990
Population genomics of intrapatient HIV-1 evolutionQ36479690
A pathway to HIV-1 neutralization breadthQ36625139
P921main subjectZambiaQ953
superinfectionQ1563808
HIV superinfectionQ4817339
P304page(s)11-19
P577publication date2019-06-15
P1433published inVirologyQ7934867
P1476titleReduced frequency of HIV superinfection in a high-risk cohort in Zambia
P478volume535

Search more.